| Literature DB >> 8310211 |
S Braune1, R Siekmann, P Vaith, C H Lücking.
Abstract
In two patients with primary antiphospholipid antibody syndrome and acute cerebrovascular ischemic events, local intraarterial fibrinolysis and intravenous heparin therapy, respectively, resulted in a limitation of persisting neurological deficits. On the basis of the 35 case reports available a combination of anticoagulation with warfarin, plus immunosuppression with steroids and/or cyclophosphamide or azathioprine, appears to be the best treatment to prevent further cerebral ischemic events. The therapeutic options are reviewed and discussed.Entities:
Mesh:
Substances:
Year: 1993 PMID: 8310211 DOI: 10.1007/BF00301266
Source DB: PubMed Journal: Rheumatol Int ISSN: 0172-8172 Impact factor: 2.631